Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Guidelines of the International Headache Society for Controlled Clinical Trials in Idiopathic Intracranial Hypertension Publisher Pubmed



Mollan SP1, 2 ; Fraser CL3 ; Digre KB4 ; Diener HC5 ; Lipton RB6 ; Juhler M7, 8 ; Miller NR9 ; Pozorosich P10, 11 ; Togha M12, 13 ; Brock K14 ; Dinkin MJ15, 16 ; Chan CKM17, 18 ; Tassorelli C19, 20 ; Sinclair AJ2, 21 Show All Authors
Authors
  1. Mollan SP1, 2
  2. Fraser CL3
  3. Digre KB4
  4. Diener HC5
  5. Lipton RB6
  6. Juhler M7, 8
  7. Miller NR9
  8. Pozorosich P10, 11
  9. Togha M12, 13
  10. Brock K14
  11. Dinkin MJ15, 16
  12. Chan CKM17, 18
  13. Tassorelli C19, 20
  14. Sinclair AJ2, 21
  15. Terwindt GM22
  16. Jensen RH23

Source: Cephalalgia Published:2023


Abstract

The quality of clinical trials is essential to advance treatment, inform regulatory decisions and meta-analysis. With the increased incidence of idiopathic intracranial hypertension and the emergence of clinical trials for novel therapies in this condition, the International Headache Society Guidelines for Controlled Clinical Trials in Idiopathic Intracranial Hypertension aims to establish guidelines for designing state-of-the-art controlled clinical trials for idiopathic intracranial hypertension. © International Headache Society 2023.
Other Related Docs
4. Therapeutic Approaches to Pediatric Pseudotumor Cerebri: New Insights From Literature Data, International Journal of Immunopathology and Pharmacology (2017)
10. Tools for Assessing Mental Health Conditions at Work: A Scoping Review, Journal of Health and Safety at Work (2025)
12. Evidence-Based Guidelines for the Pharmacological Treatment of Migraine, Cephalalgia : an international journal of headache (2025)